ST
Spyre Therapeutics Inc.
🇺🇸XNAS.SYREUnited StatesHealthcare
$91.82USDup +0.75 (+0.82%)OpenDelayed5:17 PM
Price$91.82+0.75 (+0.82%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00773J2024
- CUSIP
- 00773J202
Company
- Employees
- 125
- Headquarters
- Waltham, United States
- Website
- https://www.spyre.com
- CEO
- Dr. Cameron Turtle DPHIL, Ph.D.
Market
- Shares outstanding
- 88.2M
- Market cap
- $8.1B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $8B
- EPS LTM
- -$2.11
- P/E LTM
- -43.00
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $90.49M+100%up year on year
- Net income
- -$178.92M+13.49%up year on year
- Gross margin
- 0%
- Free cash flow
- -$208.94M-35.52%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.